Percutaneous Transluminal Angioplasty (PTA) With Stenting
On May 12, 2008, CMS reaffirmed its existing National Coverage Decision for PTA with Intracranial Stenting. Therefore, there are no changes to section 20.7. Section 20.7 is a national coverage determination (NCD). NCDs are binding on all carriers, fiscal intermediaries, quality improvement organizations, qualified independent contractors, the Medicare Appeals Council, and administrative law judges (ALJs) (see 42 CFR section 405.1060(a)(4) (2005)). An NCD that expands coverage is also binding on a Medicare advantage organization. In addition, an ALJ may not review an NCD. (See section 1869(f)(1)(A)(i) of the Social Security Act.)
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: July 11, 2008
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.